Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Lessner

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Cancer|April 1, 1977
Cancer epidemiology and the clinicianH E Lessner
Cancer|August 1, 1973
Development of four-drug BCNU combination chemotherapy regimensJ R Durant, H E Lessner
Cancer Chemotherapy Reports|May 1, 1974
Toxicity study of BCNU (NSC-409962) given orallyH E Lessner, W R Vogler
Archives of Dermatology|February 1, 1984
Hyperpigmentation with daunorubicin therapyT M Kelly, L M Fishman, H E Lessner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Prognostic factors for colon cancerS S Ellenberg, R J Mayer, H E Lessner
Cancer Treatment Reports|June 1, 1982
Combination chemotherapy with bleomycin and hydroxyurea in the treatment of advanced head and neck cancerM A Eisenberger, J Denefrio, M Silverman, et al.
Cancer Treatment Reports|January 1, 1980
Phase II study of L-asparaginase in the treatment of pancreatic carcinomaH E Lessner, S Valenstein, R Kaplan, et al.
Cancer Treatment Reports|January 1, 1981
Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectumJ M Denefrio, R S Kaplan, M A Eisenberger, et al.
Cancer Treatment Reports|June 1, 1984
Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trialG A Omura, A A Bartolucci, H E Lessner, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer|April 1, 1977
Cancer epidemiology and the clinicianH E Lessner
Cancer|August 1, 1973
Development of four-drug BCNU combination chemotherapy regimensJ R Durant, H E Lessner
Cancer Chemotherapy Reports|May 1, 1974
Toxicity study of BCNU (NSC-409962) given orallyH E Lessner, W R Vogler
Archives of Dermatology|February 1, 1984
Hyperpigmentation with daunorubicin therapyT M Kelly, L M Fishman, H E Lessner
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
Prognostic factors for colon cancerS S Ellenberg, R J Mayer, H E Lessner
Cancer Treatment Reports|June 1, 1982
Combination chemotherapy with bleomycin and hydroxyurea in the treatment of advanced head and neck cancerM A Eisenberger, J Denefrio, M Silverman, et al.
Cancer Treatment Reports|January 1, 1980
Phase II study of L-asparaginase in the treatment of pancreatic carcinomaH E Lessner, S Valenstein, R Kaplan, et al.
Cancer Treatment Reports|January 1, 1981
Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectumJ M Denefrio, R S Kaplan, M A Eisenberger, et al.
Cancer Treatment Reports|June 1, 1984
Phase II evaluation of amsacrine in colorectal, gastric, and pancreatic carcinomas: a Southeastern Cancer Study Group trialG A Omura, A A Bartolucci, H E Lessner, et al.
Pageof 1